This Month In Muscular Dystrophy

Dr. Thomas Voit Discusses Gamma Sarcoglycan Gene Therapy :: March 2012 Guest: Thomas Voit, medical and scientific director, Institut de Myologie, Paris, France Access an abstract of this month’s featured research article: A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain. 2012 Feb;135(Pt 2):483-92.